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The ability to analyze single cells via flow cytometry has resulted in a wide range of biological and medical 
applications. Currently, there is no established framework to compare and interpret time-series flow cytometry 
data for cell engineering applications. Manual analysis of temporal trends is time-consuming and subjective for 
large-scale datasets. We resolved this bottleneck by developing TEmporal Gaussian Mixture models (TEGM), 
an unbiased computational strategy to quantify and predict temporal trends of developing cell subpopulations 
indicative of cellular phenotype.  
TEGM applies Gaussian mixture models and gradient boosted trees for 
cell engineering applications. TEGM enables the extraction of subtle 
features, such as the dispersion and rate of change of surface marker 
expression for each subpopulation over time. These critical, yet hard-
to-discern, features are fed into machine-learning algorithms that 
predict underlying cell classes. Our framework can be flexibly applied 
to conventional flow cytometry sampling schemes, and allows for faster 
and more consistent processing of time-series flow cytometry data. 
 
As a proof-of-concept, we applied our method to the analysis of ex vivo 
megakaryocytic (MK) differentiation and maturation of hematopoietic 
cells from donors with varying potential to generate CD41+/CD42+ 
mature MK cells. We illustrate the major steps of the computational 
approach by predicting peak %CD41+/CD42+ MK maturation of CD34+-
selected umbilical cord blood (CB) cells from 16 independent donors 
(Figure 1). Cells were cultured over a 19-day multi-phase 
differentiation culture, consisting of a pre-expansion phase and a 
differentiation phase. The novel dataset comprised 720 measurements 
from 80 perturbations of 16 individual donors, with 9 time-point measurements sampled every 2-5 days for each 
donor. We constructed an automated gating strategy to extract surface marker expression of various clusters of 
DAPIlow/CD41+ MK cells. Notably, we demonstrate that estimation of the %CD34+ and %CD42+ cells was within 
1% of manual gating estimates, thus illustrating the consistency and accuracy of the technique. A gradient 
boosted tree model was trained using an explanatory matrix describing early characteristics and tested to 
predict peak CD41+/CD42+ marker expression. We then performed feature extraction for each flow cytometry 
time-course dataset on several descriptors, such as growth rate, viability, 
production, percentage positivity of each surface marker, covariance of mean 
fluorescence intensity, rate of change, and bifurcation of each subpopulation. A 
gradient boosted tree model was trained using an explanatory matrix describing 
early characteristics (Day 0 to Day 9) and tested to predict peak CD41+/ 
CD42+ marker expression, which typically occurs on Day 14 to Day 17.  
 
Overall, we identify several influential early culture factors that are predictive of 
peak %CD42+ expression. We show that %CD41+ on Day 5 and Day 7 is highly 
predictive, while cell viability and %CD34+ are comparatively less predictive of 
peak %CD42+. We are able to identify the best performing cultures with high 
sensitivity and specificity (AUROC = 0.92, where 1 denotes perfect accuracy). 
Predicted and actual CD41+/CD42+ responses are highly correlated using three 
independently selected partitions of test/training sets of our data (Figure 2; p = 
7.4e-09, R = 0.87). Identifying CB units with high and low MK potential early in 
the 19-day culture process can save expensive resources and time, and 
provides the potential to intervene during the culture process. 
 
Figure 2 – TEGM with 
gradient boosted tree model 
predicts peak %CD41a+/ 
CD42b+ of MK cultures. 
Figure 1 – Gaussian mixture models 
characterize each population subset 
in MK culture time-course data. 
